Inside these posts: heparin

Visit our Filed page for categories. To browse by specific topic, see our Inside page. For a list of companies covered on this site, visit our Companies page.


Pols want answers on Heparin contamination

Lawmakers scolded the FDA for still not knowing what or who was behind the contamination of the Baxter International’s blood-thinning drug Heparin, nearly three years after launching its investigation.

“It has been almost three years since the the FDA linked deaths and serious allergic reactions of patients to supplies of Heparin that came from China,“ Rep. Fred Upton (R-Mich.), wrote in a letter to FDA Commissioner Margaret Hamburg Wednesday. Upton said the House Energy and Commerce committee, which he chairs, will conduct its own probe into the matter. Get the full story »

Baxter spent over $900,000 lobbying in 3Q

Drug and medical device maker Baxter International Inc. spent $930,000 to lobby on health-care related issues in the third quarter, according to a disclosure form. The company’s lobbying budget was down slightly from $950,000 in the previous quarter. In the prior-year period, Baxter spent slightly more than $1 million on lobbying. Get the full story »

FDA accused of not pursuing leads in heparin case

From The Wall Street Journal | A Congressional committee faulted the Food and Drug Administration for not pursuing “specific and credible leads” to identify culprits in China during the 2008 crisis involving contaminated imported heparin.

Get the full story: